Firefly Neuroscience, Inc. (AIFF)

Firefly Neuroscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2.75	1.81	2.14	0.73	4.93
Cash & Short-Term Investments	2.75	1.81	2.14	0.73	4.93
Cash Growth	51.77%	-15.54%	193.13%	-85.17%	165.39%
Accounts Receivable	0.19	0.12	0.08	1.63	1.66
Inventory	0.11	-	-	-	-
Other Current Assets	0.98	0.7	0.03	0.44	0.28
Total Current Assets	4.03	2.63	2.26	2.8	6.87
Net Property, Plant & Equipment	0.15	0.14	-	0.48	0.78
Other Intangible Assets	0.86	0.18	0.39	1.18	8.05
Goodwill	5.18	-	-	1.13	7.59
Other Long-Term Assets	0.27	1.66	-	2.4	0.08
Total Assets	10.48	4.6	2.64	7.98	23.36
Accounts Payable	1.35	1.82	0.63	0.57	0.65
Accrued Expenses	0.77	1.63	1.9	1.09	0.95
Short-Term Debt	-	0.69	-	0.43	-
Current Portion of Leases	-	-	-	0.2	0.19
Unearned Revenue	0.23	0.01	-	0.18	0.19
Other Current Liabilities	0.48	0.83	-	1.42	-
Total Current Liabilities	2.82	4.98	2.53	3.89	1.98
Long-Term Leases	-	-	-	0.3	0.51
Other Long-Term Liabilities	0.02	-	-	0.06	3.43
Total Long-Term Liabilities	0.02	-	-	0.36	3.94
Total Liabilities	2.84	4.98	2.53	4.25	5.92
Common Stock	-	-	-	0	0.02
Treasury Stock	-	-	-	-0.97	-0.93
Additional Paid-in Capital	119.25	86.71	76.73	35.88	31.79
Retained Earnings	-111.62	-87.08	-76.62	-31.19	-13.44
Shareholders' Equity	7.64	-0.38	0.11	3.73	17.44
Total Liabilities & Equity	10.48	4.6	2.64	7.98	23.36
Total Debt	0	0.69	0	0.93	0.7
Net Cash (Debt)	2.75	1.12	2.14	-0.2	4.23
Net Cash Growth	146.15%	-47.92%	-	-	210.59%
Net Cash Per Share	0.22	0.17	0.66	-1.40	29.49
Book Value	7.64	-0.38	0.11	3.73	17.44
Book Value Per Share	0.61	-0.06	0.03	25.99	121.52
Tangible Book Value	1.6	-0.56	-0.28	1.42	1.81
Tangible Book Value Per Share	0.13	-0.08	-0.09	9.91	12.59

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q